Taken together, our data provide evidence suggesting that PI3K and ERK/MAPK signaling pathways are involved in Sema3E/Plexin-D1-mediated EMT in ovarian endometrioid carcinomas. The gene discussed is PLXND1; the disease is ovarian endometrioid carcinoma.